Stevanato Group S.p.A.
STVN- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001849853
In the last 90 days, Stevanato Group S.p.A. insiders filed 1 open-market purchase and 1 sale; 125 institutions reported holding it in 13F filings for Q2 2026, worth $808.8M in total; no superinvestor holds it.
- Currency
- EUR
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 2:44 PM ET
Amounts are in EUR, the currency Stevanato Group S.p.A. reports in. Lines marked ≈ US$ convert key figures to US dollars.
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F/A |
| Reported | – | – | – | – | – |
| Revenue | EUR 1.19B≈ US$1.34B | EUR 1.10B≈ US$1.19B | EUR 1.09B≈ US$1.17B | EUR 983.7M≈ US$1.04B | EUR 843.9M≈ US$998.4M |
| Cost of revenue | EUR 842.4M | EUR 801.7M | EUR 745.5M | EUR 663.9M | EUR 578.5M |
| Gross profit | EUR 343.9M | EUR 302.3M | EUR 339.9M | EUR 319.8M | EUR 265.4M |
| Research and development | EUR 25.4M | EUR 31.7M | EUR 35.7M | EUR 34.4M | EUR 29.6M |
| Selling, general and administrative | EUR 99.7M | EUR 93.7M | EUR 88.9M | EUR 85.7M | EUR 62.5M |
| Operating income | EUR 198.8M | EUR 161.1M | EUR 200.7M | EUR 192.4M | EUR 162.2M |
| Interest expense | EUR 22.7M | EUR 23.2M | EUR 31.4M | EUR 29.8M | EUR 18.8M |
| Income tax | EUR 49.3M | EUR 42.5M | EUR 43.9M | EUR 44.6M | EUR 31.4M |
| Net income | EUR 139.8M≈ US$158.1M | EUR 117.8M≈ US$127.4M | EUR 145.7M≈ US$157.6M | EUR 143.0M≈ US$150.7M | EUR 134.3M≈ US$158.8M |
| EPS, basic | EUR 0.51 | EUR 0.43 | EUR 0.55 | EUR 0.54 | EUR 0.53 |
| EPS, diluted | EUR 0.51 | EUR 0.43 | EUR 0.55 | EUR 0.54 | EUR 0.53 |
| Weighted shares, basic | 273.0M | 271.1M | 265.0M | 264.7M | 252.7M |
| Weighted shares, diluted | 273.0M | 271.2M | 265.0M | 264.7M | 252.7M |
| Margins and growth | |||||
| Gross margin | 29.0% | 27.4% | 31.3% | 32.5% | 31.4% |
| Operating margin | 16.8% | 14.6% | 18.5% | 19.6% | 19.2% |
| Net margin | 11.8% | 10.7% | 13.4% | 14.5% | 15.9% |
| Revenue growth, year over year | +7.4% | +1.7% | +10.3% | +16.6% | – |
| Net income growth, year over year | +18.7% | −19.2% | +1.9% | +6.5% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F/A |
| Reported | – | – | – | – | – |
| Cash and equivalents | EUR 130.6M | EUR 98.3M | EUR 69.6M | EUR 228.7M | EUR 411.0M |
| Accounts receivable | EUR 302.7M | EUR 296.0M | EUR 301.8M | EUR 212.7M | EUR 165.3M |
| Inventory | EUR 268.2M | EUR 245.2M | EUR 255.3M | EUR 213.3M | EUR 148.9M |
| Total current assets | EUR 943.4M | EUR 880.1M | EUR 861.9M | EUR 845.8M | EUR 866.0M |
| Property, plant and equipment | EUR 1.39B | EUR 1.25B | EUR 1.03B | EUR 641.4M | EUR 392.7M |
| Goodwill | EUR 50.0M | EUR 50.0M | EUR 50.0M | EUR 47.2M | EUR 47.2M |
| Intangible assets | EUR 36.9M | EUR 33.6M | EUR 31.0M | EUR 32.2M | EUR 31.9M |
| Total assets | EUR 2.54B≈ US$2.99B | EUR 2.33B≈ US$2.41B | EUR 2.07B≈ US$2.29B | EUR 1.66B≈ US$1.78B | EUR 1.42B≈ US$1.61B |
| Accounts payable | EUR 341.7M | EUR 297.8M | EUR 354.1M | EUR 308.7M | EUR 230.6M |
| Total current liabilities | EUR 535.9M | EUR 477.5M | EUR 574.4M | EUR 462.5M | EUR 338.6M |
| Total liabilities | EUR 1.06B | EUR 924.4M | EUR 938.9M | EUR 663.8M | EUR 577.2M |
| Shareholders' equity | EUR 1.49B | EUR 1.40B | EUR 1.13B | EUR 995.9M | EUR 841.7M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F/A |
| Reported | – | – | – | – | – |
| Operating cash flow | EUR 286.1M≈ US$323.4M | EUR 155.8M≈ US$168.5M | EUR 105.2M≈ US$113.8M | EUR 103.3M≈ US$108.8M | EUR 133.3M≈ US$157.7M |
| Capital expenditures | EUR 263.8M | EUR 302.6M | EUR 433.2M | EUR 235.0M | EUR 107.7M |
| Free cash flow | EUR 22.3M≈ US$25.2M | EUR -146.8M≈ US-$158.9M | EUR -328.0M≈ US-$354.8M | EUR -131.7M≈ US-$138.8M | EUR 25.6M≈ US$30.3M |
| Depreciation and amortization | – | – | EUR 78.5M | EUR 64.8M | EUR 56.4M |
| Dividends paid | EUR 14.7M | EUR 14.5M | EUR 14.3M | EUR 13.5M | EUR 11.2M |
| Investing cash flow | EUR -272.9M | EUR -310.2M | EUR -421.2M | EUR -242.9M | EUR -96.4M |
| Financing cash flow | EUR 22.1M | EUR 183.2M | EUR 158.0M | EUR -44.5M | EUR 254.8M |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
- ≈ US$ figures convert EUR at FRED H.10 exchange rates (Federal Reserve): the average rate over the period for income and cash flow, and the rate on the period-end date, or the last business day before it, for the balance sheet.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.